Related Experiment Video
Updated: Mar 8, 2026
Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
Published on: March 14, 2013
Modern LC-MS strategies for comprehensive metabolite identification of therapeutic oligonucleotides
Devendra Kumar1, Nilesh Dahibhate2, Neerja Trivedi3
1Department of Pediatrics, Hematology/Oncology Division, University of Nebraska Medical Center, Omaha, NE, USA.
Abstract:
Therapeutic oligonucleotides (ONs), including antisense-oligonucleotides, small interfering RNA, aptamers, and conjugated modalities, have emerged as an important class of drugs with increasing clinical impact. Unlike small molecules, ONs undergo metabolism primarily through nuclease-mediated cleavage, generating complex profiles of shortened metabolites that often differ by a single nucleotide and may retain pharmacological or toxicological relevance. Comprehensive metabolite identification is therefore essential for understanding ONs pharmacokinetics (PK), tissue exposure, and safety. Liquid chromatography coupled to mass spectrometry (LC-MS) has become the principal analytical platform for ONs metabolite identification. Recent advances in chromatographic separation, high-resolution mass spectrometry, fragmentation strategies, and data processing tools have substantially improved the depth, confidence, and throughput of metabolite characterization. This review provides an overview of ONs biotransformation pathways and critically examines modern LC-MS strategies used for metabolite separation, detection, and structural elucidation. Emphasis is placed on high-resolution MS acquisition approaches, charge-state management, complementary fragmentation techniques, and software-assisted metabolite annotation. Emerging trends and future directions in ONs metabolite analysis are also discussed, with a focus on supporting translational PK and regulatory decision making.
Insights
Therapeutic oligonucleotides (ONs) are metabolized by nucleases, creating complex metabolite profiles. Advanced liquid chromatography-mass spectrometry (LC-MS) techniques are crucial for identifying these ON metabolites to ensure drug safety and efficacy.
Area of Science:
- Pharmacology and Drug Development
- Analytical Chemistry
- Biochemistry
Background:
- Therapeutic oligonucleotides (ONs) are a growing class of drugs with significant clinical applications.
- ON metabolism differs from small molecules, primarily involving nuclease-mediated cleavage.
- Metabolite identification is critical for understanding ON pharmacokinetics, tissue distribution, and potential toxicity.
Purpose of the Study:
- To review oligonucleotide (ON) biotransformation pathways.
- To examine modern liquid chromatography-mass spectrometry (LC-MS) strategies for ON metabolite identification.
- To discuss emerging trends in ON metabolite analysis for translational research and regulatory purposes.
Main Methods:
- Utilized liquid chromatography coupled to mass spectrometry (LC-MS) as the principal analytical platform.
- Reviewed advances in chromatographic separation, high-resolution mass spectrometry, and fragmentation techniques.
- Examined software-assisted metabolite annotation and data processing tools.
Main Results:
- Nuclease-mediated cleavage generates complex ON metabolite profiles, often differing by a single nucleotide.
- Modern LC-MS strategies offer improved depth, confidence, and throughput for metabolite characterization.
- High-resolution MS, advanced fragmentation, and data processing enhance structural elucidation.
Conclusions:
- Comprehensive identification of ON metabolites is essential for assessing pharmacokinetics, tissue exposure, and safety.
- Advanced LC-MS techniques are vital for detailed characterization of ON metabolites.
- Future directions focus on supporting PK studies and regulatory decision-making in oligonucleotide drug development.
More Related Videos
11:00Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS
Published on: May 20, 2013
14:42Liquid Chromatography Coupled to Refractive Index or Mass Spectrometric Detection for Metabolite Profiling in Lysate-based Cell-free Systems
Published on: September 23, 2021
